316 related articles for article (PubMed ID: 19918435)
1. Extremely high doses of radioiodine required for treatment of Graves' hyperthyroidism: a case report.
Neto AM; Tambascia MA; Brunetto S; Ramos CD; Zantut-Wittmann DE
Cases J; 2009 Aug; 2():8479. PubMed ID: 19918435
[TBL] [Abstract][Full Text] [Related]
2. Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation.
Mihailescu DV; Hoscheit C; Fogelfeld L
Endocr Pract; 2024 Apr; 30(4):333-339. PubMed ID: 38307459
[TBL] [Abstract][Full Text] [Related]
3. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
[TBL] [Abstract][Full Text] [Related]
4. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine treatment of hyperthyroidism in cats: results of 165 cats treated by an individualised dosing algorithm in Spain.
Xifra P; Serrano SI; Peterson ME
J Feline Med Surg; 2022 Aug; 24(8):e258-e268. PubMed ID: 35748791
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine Therapy-Induced Conversion of Toxic Adenoma to Graves' Disease.
Rehman A; Obici S; Yaqub A
Cureus; 2020 Jun; 12(6):e8683. PubMed ID: 32699683
[TBL] [Abstract][Full Text] [Related]
7. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
8. Thyroid volume is the key predictor of hyperthyroidism remission after radioactive iodine therapy in pediatric patients.
Sheremeta M; Korchagina M; Trukhin A; Nagaeva E; Bezlepkina O; Peterkova V
Eur J Pediatr; 2023 Nov; 182(11):4931-4937. PubMed ID: 37606704
[TBL] [Abstract][Full Text] [Related]
9. Graves' disease coexisted with resistance to thyroid hormone: a case report.
Akahori H; Usuda R
J Med Case Rep; 2021 Sep; 15(1):473. PubMed ID: 34560890
[TBL] [Abstract][Full Text] [Related]
10. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
11. Graves Disease Following Subacute Thyroiditis in a Chinese Man.
Al-Bacha S; Lahiri SW
AACE Clin Case Rep; 2022; 8(2):73-77. PubMed ID: 35415228
[TBL] [Abstract][Full Text] [Related]
12. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
13. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function tests of iodine deficiency goiter can mimic thyroid hormone resistance alpha.
Sasidharan Pillai S; Quintos JB
J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1433-1436. PubMed ID: 36100365
[TBL] [Abstract][Full Text] [Related]
16. Recurrent Graves' hyperthyroidism after prolonged radioiodine-induced hypothyroidism.
Salman F; Oktaei H; Solomon S; Nyenwe E
Ther Adv Endocrinol Metab; 2017 Jul; 8(7):111-115. PubMed ID: 28944001
[TBL] [Abstract][Full Text] [Related]
17. Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter.
Riguetto CM; Miguel VP; Pavin EJ; Amorim BJ; Ramos CD; Zantut-Wittmann DE
Nucl Med Commun; 2020 Aug; 41(8):727-732. PubMed ID: 32427701
[TBL] [Abstract][Full Text] [Related]
18. Graves' disease with only unilateral involvement; a case report.
Bu Bshait MS
Int J Surg Case Rep; 2024 Jan; 114():109138. PubMed ID: 38086135
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
[TBL] [Abstract][Full Text] [Related]
20. Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report.
Toda S; Kadoya M; Matsui A; Murayama D; Iwasaki H
Ann Palliat Med; 2022 Nov; 11(11):3571-3577. PubMed ID: 35726194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]